Neumora’s navacaprant has completed a clean sweep of trial misses in major depressive disorder.
- Home |
- Neumora to lay off 35% of staff after navacaprant goes 0 for 3 in late-stage depression studies
Neumora to lay off 35% of staff after navacaprant goes 0 for 3 in late-stage depression studies
- June 15, 2026
Recent Posts
- LNG market tightens into winter as Europe pulls US cargoes, China reopens contract talks
- EIA: US crude oil inventories down 3.2 million bbl
- Chevron restructures Bakken midstream agreements, transfers Hess Midstream stake
- Cenovus to build oil sands business via Athabasca acquisition
- Centalion acquires Haynesville gas assets from Silver Hill
